BA
WST icon

Bellwether Advisors’s West Pharmaceutical WST Stock Holding History

Bellwether Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$438 – 582
2025
Q2 		$438 Sell
2
-5,271
-100% -$1.13M ﹤0.01% 547
2025
Q1 		$1.18M Buy
+5,273
New +$1.45M 0.25% 61
2024
Q3 		– Sell
-2,265
Closed -$746K – 148
2024
Q2 		$746K Sell
2,265
-3,732
-62% -$1.32M 0.16% 78
2024
Q1 		$2.37M Sell
5,997
-12,660
-68% -$4.68M 0.52% 50
2023
Q4 		$6.57M Buy
+18,657
New +$6.6M 1.62% 16
2022
Q2 		– Sell
-16
Closed -$6K – 592
2022
Q1 		$6K Hold
16
– – ﹤0.01% 351
2021
Q4 		$7K Hold
16
– – ﹤0.01% 368
2021
Q3 		$6K Buy
+16
New +$6.75K ﹤0.01% 359

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bellwether Advisors's WST Position: Q3 2025 in Review

Bellwether Advisors sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 2 shares — an estimated $438 sold.

Bellwether Advisors first reported a position in WST in Q3 2021 and held it in 8 quarters. The position peaked at $6.57M in Q4 2023. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Bellwether Advisors reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Bellwether Advisors sold 2 West Pharmaceutical shares in Q3 2025, an estimated $438.
  • Bellwether Advisors first reported a position in West Pharmaceutical in Q3 2021 and held it in 8 quarters.
  • Bellwether Advisors's West Pharmaceutical position peaked at $6.57M in Q4 2023.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.